Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome®

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 1, 1997, Pages 77-

  Sampaio, Raimunda Nonata Ribeiro ^a   Marsden, Philip Davis ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Ambisome ; Chemotherapy; Leishmania braziliensis; Leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MEGLUMINE ANTIMONATE;

ADULT; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; MALE; MUCOSA INFLAMMATION; SHORT SURVEY;

EID: 12644317853     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90404-1     Document Type: Article

References (5)

1. Davidson, R. N., Croft, S. L., Scott, A., Maini, M., Moody, A. H. & Bryceson, A. D. M. (1991). Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet, 337, 1061-1062.
2. Grogl, M., Thomason, T. N. & Franke, E. D. (1992). Drug resistence in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. American Journal of Tropical Medicine and Hygiene, 47, 117-126.
3. Marsden, P. D. (1985). Mucosal leishmaniasis ('espundia' Escomel, 1911). Transactions of the Royal Society of Tropical Medicine and Hygiene, 80, 859-876.
4. Sampaio, R. N. R., Sampaio, J. H. D. & Marsden, P. D. (1985). Pentavalent antimonial therapy in mucosal leishmaniasis. Lancet i, 1097.
5. Thakur, C. P., Pandey, A. K., Sinha, G. P., Roy, S., Behbehani, K. & Olliaro, P. (1996). Comparison of three treatment regimens with liposomal amphotericin B (AmBisome™) for visceral leishmaniasis in India: a randomized dose-finding study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 319-322.